Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SYNPO2L antisense RNA 1 (SYNPO2L-AS1) is a long non-coding RNA transcribed antiparallel to the SYNPO2L gene locus. Its main biological function has not been experimentally established, but by analogy with other antisense RNAs, it may affect the expression of the sense SYNPO2L gene via cis or trans regulatory mechanisms. Antisense non-coding RNAs can regulate gene expression at various molecular levels, including transcriptional interference, modification of chromatin structure, or post-transcriptional regulation such as mRNA stability and translation. No evidence currently supports SYNPO2L-AS1 as a direct therapeutic target, biomarker, or interactor for drugs, nor is it linked to any specific disease independently of the SYNPO2L protein-coding gene.
None established for any drug
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SYNPO2L antisense RNA 1 (SYNPO2L-AS1).